Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome

ÇUBUKÇU E., Olmez O. F., SARAYDAROĞLU Ö., Akcali U., Kanat O., Kurt E., ...More

CLINICAL & TRANSLATIONAL ONCOLOGY, vol.13, no.11, pp.826-830, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 11
  • Publication Date: 2011
  • Doi Number: 10.1007/s12094-011-0741-7
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.826-830
  • Keywords: Non-small-cell lung cancer, Excision repair cross-complementing 1, Immunohistochemistry, Prognosis, DNA-REPAIR, MESSENGER-RNA, CHEMOTHERAPY, BIOMARKERS, RESISTANCE, THERAPY, GENE
  • Bursa Uludag University Affiliated: Yes


The identification of novel prognostic markers may help to better assess survival probability in different subgroups of patients with non-small-cell lung cancer (NSCLC) and to tailor treatment according to the molecular profile of the tumour.